Didier Mesangeau

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 94(Granted Patents)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

Merck Patent Gesellschaft MIT

patents

8. 1 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

9. 1 out of 121

Merck Patent Gesellschaft

patents

where one patent can have more than one assignee

Years Active: 2000-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9035048 - Tetrahydrotriazine compounds for treating diseases associated with AMPK activity (2015-05-19),

2. 8980828 - Combination of insulin with triazine derivatives and its use for treating diabetes (2015-03-17),

3. 8937066 - Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases (2015-01-20),

4. 8791115 - Combination of triazine derivatives and insulin sensitisers (2014-07-29),

5. 8592370 - Combination of insulin with triazine derivatives (2013-11-26),

6. 8227465 - Combination of triazine derivatives and insulin secretion stimulators (2012-07-24),

7. 7767676 - Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses (2010-08-03),

8. 7452883 - Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses (2008-11-18),

9. 7034021 - Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses (2006-04-25),

10. 6518458 - (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy (2003-02-11),

11. 6437143 - Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same (2002-08-20),

12. 6376495 - Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them (2002-04-23),

13. 6143787 - Pharmaceutical composition containing 4-oxo-butynic acids (2000-11-07),

Title: The Innovative Contributions of Didier Mesangeau

Introduction

Didier Mesangeau is a prominent inventor based in Combs la Ville, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target various physiological conditions. With a total of 13 patents to his name, Mesangeau's work has the potential to impact the treatment of diseases associated with AMP-activated protein kinase (AMPK) activity.

Latest Patents

One of Mesangeau's latest patents involves the creation of tetrahydrotriazine compounds for treating diseases associated with AMPK activity. This invention relates to compounds of a specific formula, which can be used for the prophylactic or therapeutic treatment of conditions linked to AMPK activity. The compounds aim to enhance glucose homeostasis, improve podocytopathy, and decrease the production of reactive oxygen species (ROS). Additionally, the patent includes methods for in-vitro diagnosing diabetic nephropathy and screening compounds that reduce podocytopathy using synaptopodin as a biomarker.

Another notable patent focuses on the combination of insulin with triazine derivatives for treating diabetes. This invention describes a pharmaceutical composition that includes insulin and at least one compound of a specified formula. The composition is designed for the prophylactic or therapeutic treatment of conditions associated with insulin resistance. Furthermore, it outlines a pharmaceutical package that contains insulin in one dosage unit and a triazine derivative in another.

Career Highlights

Throughout his career, Didier Mesangeau has worked with reputable companies such as Poxel S.a.s. and Merck Santé. His experience in these organizations has contributed to his expertise in the field of pharmaceutical development and innovation.

Collaborations

Mesangeau has collaborated with notable colleagues, including Daniel Cravo and Liliane Doare. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Didier Mesangeau's innovative work in medicinal chemistry and his numerous patents highlight his significant contributions to the field. His inventions have the potential to advance treatments for various diseases, particularly those related to insulin resistance and AMPK activity.

This text is generated by artificial intelligence and may not be accurate.